The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $49.95

Today's change+0.34 +0.69%
Updated March 27 4:04 PM EDT. Delayed by at least 15 minutes.
 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $49.95

Today's change+0.34 +0.69%
Updated March 27 4:04 PM EDT. Delayed by at least 15 minutes.

Tenet Healthcare Corp crosses above 125-day moving average

Tenet Healthcare Corp closed up Friday by (U.S.)$0.34 or 0.69% to (U.S.)$49.95 and crossing above its 125-day moving average. Over the last five days, shares have gained 0.67%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 7.86% during the last year.

Key company metrics

  • Open(U.S.) $49.58
  • Previous close(U.S.) $49.61
  • High(U.S.) $50.17
  • Low(U.S.) $49.37
  • Bid / Ask-- / --
  • YTD % change-1.42%
  • Volume1,215,652
  • Average volume (10-day)1,758,023
  • Average volume (1-month)1,912,347
  • Average volume (3-month)1,883,451
  • 52-week range(U.S.) $37.95 to (U.S.) $63.61
  • Beta2.02
  • Trailing P/E177.00×
  • P/E 1 year forward24.72×
  • Forward PEG1.60×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.28
Updated March 27 4:04 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.39%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2014Q3/2014Q2/2014Q1/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue4,4684,1794,0423,926
Total other revenue--------
Total revenue4,4684,1794,0423,926
Gross profit3,7803,5143,3933,298
Total cost of revenue688665649628
Total operating expense4,1313,9923,8353,756
Selling / general / administrative2,1182,0281,9561,921
Research & development--------
Depreciation / amortization240207209193
Interest expense (income), net operating--------
Unusual expense (income)69654424
Other operating expenses, total1,0161,027977990
Operating income337187207170
Interest income (expense), net non-operating-196-186-190-182
Gain (loss) on sale of assets--------
Other--------
Income before tax141117-12
Income after tax81199-11
Income tax, total60-188-1
Net income619-26-32
Total adjustments to net income--------
Net income before extra. items6110-10-27
Minority interest-20-9-19-16
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6110-10-27
Inc. avail. to common incl. extra. items619-26-32
Diluted net income619-26-32
Dilution adjustment------0
Diluted weighted average shares1081019897
Diluted EPS excluding extraordinary itemsvalue per share0.560.10-0.10-0.28
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.930.520.14-0.12